Abstract
Introduction
It was previously shown that intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) prior to GnRH mobilization in proestrus prevents ovulation in rats. In this study, we examined whether PACAP given intranasally could influence luteinizing hormone (LH) and prolactin (PRL) surges and ovulation.
Methods
On the day of proestrus PACAP, p-cyclodextrin (modifier of blood-brain barrier) or PACAP + p-cyclodextrin was applied intranasally between 12:30 and 13:00. Blood samples were taken at 16:00, 18:00, and 20:00 for measuring plasma hormone levels. In the next morning, the expelled ova were counted. p-Cyclodextrin was also administered to male and diestrous female rats between 12:30 and 13:00 and blood was taken at 18:00.
Results
PACAP prevented LH and PRL surges and ovulation in about half of the rats, p-cyclodextrin alone more effectively prevented ovulation. When PACAP and p-cyclodextrin were administered together, more rats ovulated like when PACAP given alone. p-Cyclodextrin did not influence LH and PRL levels in diestrous females; however, in males, it significantly enhanced PRL level.
Discussion
Not only the intracerebroventricular, but the intranasal application of PACAP prevented ovulation. p-Cyclodextrin alone is more effective than PACAP and enhances PRL levels in male rats. PACAP and p-cyclodextrin given together weaken each other’s effect. p-Cyclodextrin, as excipient of various drugs, has to be used carefully in human medications.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arimura, A. (2007) PACAP: the road to discovery. Peptides 28, 1617–1619.
Arimura, A., Shioda, S. (1995) Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front. Neuroendocrinal. 16, 53–88.
Arora, P., Sharma, S., Garg, S. (2002) Permeability issues in nasal drug delivery. Drug. Discov. Today 7, 967–975.
Banks, W. A. (2015) Peptides and the blood-brain barrier. Peptides 72, 16–19.
Barr, G. D., Barraclough, C. A. (1978) Temporal changes in medial basal hypothalamic LH-RH correlated with plasma LH during the rat estrous cycle and following electrochemical stimulation of the medial preoptic area in pentobarbital-treated proestrous rats. Brain Res. 148, 413–423.
Bokaei, P. B., Ma, X. Z., Byczynski, B., Keller, J., Sakac, D., Fahim, S., Branch, D. R. (2006) Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors. Genomics 88, 791–800.
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., Fehm, H. L. (2002) Sniffing neuropeptides: a transport to the human brain. Nat. Neurosci. 5, 514–516.
Butcher, R. L., Collins, W. E., Fugo, N. W. (1974) Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17p throughout the 4-day estrous cycle of the rat. Endocrinology 94, 1704–1708.
Charlton, S. T., Davis, S. S., Ilium, L. (2007) Nasal administration of an angiotensin antagonist in the rat model: effect of bioad-hesive formulations on the distribution of drugs to the systemic and central nervous systems. Int. J. Pharm. 338, 94–103.
Counis, R., Laverriere, J. N., Garrel-Lazayres, G., Cohen-Tannoudji, J., Lariviere, S., Bleux, C., Magre, S. (2007) What is the role of PACAP in gonadotrope function? Peptides 28, 1797–1804.
Everett, J. W., Sawyer, C. H. (1950) A 24-hour periodicity in the “LH-release apparatus” of female rats, disclosed by barbiturate sedation. Endocrinology 47, 198–218.
Gottschall, P. E., Tatsuno, I., Arimura, A. (1991) Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification. FASEB J. 5, 194–199.
Gottschall, P. E., Tatsuno, I., Miyata, A., Arimura, A. (1990) Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 127, 272–277.
Gras, S., Hannibal, J., Georg, B., Fahrenkrug, J. (1996) Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. Endocrinology 137, 4779–1785.
Greenwood, F. C., Hunter, W. M., Glover, J. S. (1963) The preparation of 1-131-labelled human growth hormone of high specific radioactivity. Biochem. J. 89, 114–123.
Guthoff, M., Grichisch, Y., Canova, C., Schritter, O., Veit, R., Hallschmid, M., Haring, H. U., Preissl, H., Hennige, A. M., Fritsche, A. (2010) Insulin modulates food-related activity in the central nervous system. J. Clin. Endocrinol. Metab. 95, 748–755.
Heinzlmann, A., Kirilly, E., Meltzer, K., Szabo, E., Baba, A., Hashimoto, H., Koves, K. (2008) PACAP is transiently expressed in anterior pituitary gland of rats. In situ hybridization and cell immunoblot assay studies. Peptides 29, 571–577.
Heinzlmann, A., Kiss, G., Dochnal, R., Pal, A., Sipos, I., Manczinger, M., Szabo, Gy., Koves, K. (2012) Intranasal application of secretin, similarly to intracerebroventricular administration, influences the behavior of mice. J. Mol. Neurosci. 48, 558–564.
Hermens, W. A., Deurloo, M. J., Romeyn, S. G., Verhoef, J. C., Merkus, F. W. (1990) Nasal absorption enhancement of 17 p-estradiol by dimethyl-p-cyclodextrin in rabbits and rats. Pharm. Res. 7, 500–503.
Ilium, L. (2004) Is nose-to-brain transport of drugs in man a reality? J. Pharm. Pharmacol. 56, 3–17.
Isaac, E. R., Sherwood, N. M. (2008) Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice. Mol. Cell. Endocrinol. 280, 13–19.
Kantor, O., Molnar, J., Heinzlmann, A., Furst, Zs., Arimura, A., Koves, K. (2000) The inhibitory effect of PACAP38 on ovulation is mediated by CRF and endogenous opioids. Ann. N Y. Acad. Set 921, 405–409.
Koppan, M., Varnagy, A., Reglodi, D., Brubel, R., Nemeth, J., Tamas, A., Mark, L., Bodis, J. (2012) Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment. J. Mol. Neurosci. 48, 617–622.
Koves, K., Kantor, O., Heinzlmann, A., Lakatos, A., Szabo, E., Kirilly, E., Szabo, F. K. (2014) Advent and recent advance of the research on the role of pituitary adenylate cyclase activating polypeptide (PACAP) in the gonadotropic hormone secretion. J. Mol. Neurosci. 54, 494–511.
Koves, K., Kantor, O., Vereczki, V., Kausz, M., Nemeskeri, A., Fogel, K., Kiss, A., Gores, T. J., Szeiffert, G., Arimura, A. (2000) PACAP and VIP in the photoneuroendocrine system: from the retina to the pituitary gland. Ann. N. Y. Acad. Sci. 921, 321–326.
Koves, K., Marton, J., Molnar, J., Halasz, B. (1981) (D-Met2, Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat. Neuroendocrinology 32, 82–86.
Koves, K., Molnar, J., Kantor, O., Gores, T., Arimura, A. (1996) New aspects of the neuroendocrine role of PACAP. Ann. N Y. Acad. Sci. 805, 648–654.
Kubek, M. J., Domb, A. J., Veronesi, M. C. (2009) Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles. Neurotherapeutics 6, 359–371.
Lee, E. H., Seo, S. R. (2014) Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases. BMB Rep. 47, 369–75.
Lochhead, J. J., Wolak, D. J., Pizzo, M. E., Thome, R. G. (2015) Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J. Cereb. Blood Flow. Metab. 35, 71–81.
Loftsson, T., Brewster, M. E. (2010) Pharmaceutical applications of cyclodextrins: basic science and product development. J. Pharm. Pharmacol. 62, 1607–1621.
Merkus, F. W., Verhoef, J. C., Marttin, E., Romeijn, S. G., van der Kuy, P. H., Hermens, W. A., Schipper, N. G. (1999) Cyclodextrins in nasal drug delivery. Adv. Drug Deliv. Rev. 36, 41–57.
Miyata, A., Arimura, A., Dahl, R. R., Minamino, N., Uehara, A., Jiang, L., Culler, M. D., Coy, D. H. (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 18, 567–574.
Miyata, A., Jiang, L., Dahl, R. D., Kitada, C., Kubo, K., Fujino, M., Minamino, N., Arimura, A. (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170, 643–648.
Moore, J. P. Jr., Burger, L. L., Dalkin, A. C., Winters, S. J. (2005) Pituitary adenylate cyclase activating polypeptide messenger RNA in the paraventricular nucleus and anterior pituitary during the rat estrous cycle. Biol. Reprod. 73, 491–199.
Nonaka, N., Farr, S. A., Nakamachi, T., Morley, J. E., Nakamura, M., Shioda, S., Banks, W. A. (2012) Intranasal administration of PACAP: uptake by brain and brain region targeting with cyclodextrins. Peptides 36, 168–175.
Numanoglu, U., Sen, T., Tarimci, N., Kartal, M., Koo, O. M. Y., Onyuksel, H. (2007) Use of cyclodextrins as a cosmetic delivery system for fragrance materials: linalool and benzyl acetate. AAPS Pharm. Sci. Tech. 8, 34–42.
Ohtaki, T., Watanabe, T., Ishibashi, Y., Kitada, C., Tsuda, M., Gottschall, P. E., Arimura, A., Fujino, M. (1990) Molecular identification of receptor for pituitary adenylate cyclase activating polypeptide. Biochem. Biophys. Res. Commun. 171, 838–44.
Park, J. Y., Park, J. H., Park, H. J., Lee, J. Y., Lee, Y. I., Lee, K., Chun, S. Y. (2001) Stage-dependent regulation of ovarian pituitary adenylate cyclase-activating polypeptide mRNA levels by GnRH in cultured rat granulosa cells. Endocrinology 142, 3828–3835.
Pietrowsky, R., Thiemann, A., Kern, W., Fehm, H. L., Born, J. (1996) A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystoki-nin. Psychoneuroendocrinology 21, 559–572.
Rawlings, S. R. (1994) PACAP, PACAP receptors, and intracellular signalling. Mol. Cell Endocrinol. 101, C5-C9.
Reglodi, D., Somogyvari-Vigh, A., Vigh, S., Maderdrut, J. L., Arimura, A. (2000) Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions. Ann. N. Y. Acad. Sci. 921, 119–128.
Reglodi, D., Tamas, A., Koppan, M., Szogyi, D., Welke, L. (2012) Role of PACAP in female fertility and reproduction at gonadal level - recent advances. Front. Endocrinol. 3, article 155.
Sherwood, N. M., Adams, B. A., Isaac, E. R., Wu, S., Fradinger, E. A. (2007) Knocked down and out: PACAP in development, reproduction and feeding. Peptides 28, 1680–1687.
Szabo, E., Nemeskeri, A., Arimura, A., Koves, K. (2004) Effect of PACAP on LH release, studied by cell immunoblot assay, depends on the gender, on the time of day and in female rats on the day of estrous cycle. Regul. Pep. 123, 139–145.
Szejtli, J. (1988) Cyclodextrin Technology. Kluwer, Dordrecht, The Netherlands.
Szejtli, J., Szente, L. (2005) Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur. J. Pharm. Biopharm. 61, 115–125.
Tamas, A., Reglodi, D., Farkas, O., Kovesdi, E., Pal, J., Povlishock, J. T., Schwarcz, A., Czeiter, E., Szanto, Z., Doczi, T., Buki, A., Bukovics, P. (2012) Effect of PACAP in central and peripheral nerve injuries. Int. J. Mol. Sci. 13, 8430–8448.
Tiwari, G., Tiwari, R., Sriwastawa, B., Bhati, L., Pandey, S., Pandey, P., Bannerjee, S. K. (2012) Drug delivery systems: an updated review. Int. J. Pharm. Invest. 2, 2–11.
Vecsernyes, M., Fenyvesi, F., Bacskay, I., Deli, M. A., Szente, L., Fenyvesi, E. (2014) Cyclodextrins, blood-brain barrier, and treatment of neurological diseases. Arch. Med. Res. 45, 711–729.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited, a link to the CC License is provided, and changes — if any — are indicated. (SID_1).
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Heinzlmann, A., Oláh, M. & Köves, K. Intranasal application of PACAP and β-cyclodextrin before the “critical period of proestrous stage” can block ovulation. BIOLOGIA FUTURA 70, 62–70 (2019). https://doi.org/10.1556/019.70.2019.08
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1556/019.70.2019.08